Pralatrexate effectively inhibits the replication of monkeypox virus in vitro and in vivo

文献类型： 外文期刊

第一作者： Li, Jianshu

作者： Li, Jianshu;Li, Siyu;Gu, Chaode;Wu, Zhiwei;He, Miao;Wu, Zhiwei;Wu, Zhiwei;Shi, Shaowen;Li, Xiao;Guo, Zhendong;Zhao, Zongzheng

作者机构：

关键词： Pralatrexate; MPXV; Antiviral; Poxviruses

期刊名称：ANTIVIRAL RESEARCH （ 影响因子：4.0； 五年影响因子：4.3 ）

ISSN： 0166-3542

年卷期： 2025 年 241 卷

页码：

收录情况： SCI

摘要： The monkeypox virus (MPXV), an orthopoxvirus, has caused a number of major outbreaks and emerged as a global public health threat. Although drugs have been approved for the treatment of mpox, the efficacy and side effects remain unknown, which calls for the development of safe and effective drugs. Pralatrexate (PDX) is a fourth-generation antifolate drug with inhibitory activity against a wide range of viruses. In this study, we demonstrated the antiviral activity of PDX against MPXV in vitro and in vivo. Our results showed that PDX potently inhibited the MPXV replication at very low drug concentrations in vitro, and could significantly inhibit MPXV activity in dormice. In conclusion, this study found that PDX is an effective antiviral drug against MPXV infection, showing potential as a novel therapy for MPXV infection.

分类号：

  • 相关文献
作者其他论文 更多>>

微信小程序